Rapport 2012 sur les médicaments génériques [Internet]. [cité 29 juill 2013]. Disponible sur: http://www.medicamentsgeneriques, pp.2012-2024, 2009. ,
Points sur les médicaments génériques [Internet]. [cité 29 juill 2013, Disponible sur ,
Avenant n°1 à l'accord local du 21 février 2007 relatif à la délivrance des médicaments génériques ,
Dispositif tiers payant contre générique Quelle facturation pour le pharmacien? ,
Médicaments et produits de santé [Internet]. [cité 29 juill 2013]. Disponible sur: http://www.hc-sc.gc.ca/dhp-mps ,
Article C.08.002.1 Règlement sur les aliments et drogues [Internet]. 2013 [cité 29 juill 2013]. Disponible sur: http://lawslois .justice.gc.ca, %2C_ch._870, pp.296-309 ,
Role 6: Gérer les médicaments.pdf [Internet]. [cité 29 juill 2013]. Disponible sur: http://guide.opq.org ,
ANalysis Of Variance [Internet]. [cité 30 juill 2013, Disponible sur ,
Disponible sur: http://www.gbs-vbs.org/lms, pp.402-406, 2013. ,
Les médicaments génériques: panacée ou illusion? Pharma-Flash, p.1, 2003. ,
Therapeutic index, CME at Pharmacology Corner ,
Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharmacy Practice, pp.50-55, 2010. ,
Development & Approval Process (Drugs) -Orange Book Preface ,
Mythes et réalités, 2012. ,
Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review, PLoS ONE, vol.24, issue.8, p.23611, 2011. ,
DOI : 10.1371/journal.pone.0023611.s008
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration, Annals of Pharmacotherapy, vol.84, issue.9, pp.1583-1597, 2009. ,
DOI : 10.1345/aph.1M141
Biowaivers: Criteria and Requirements, International Journal of Pharmaceutical & Biological Archives, vol.3723, issue.4, pp.727-731487, 2012. ,
Waiver of In Vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System Disponible sur: http://www.fda.gov Biopharmaceutics Classification System and formulation development, Internet]. [cité 30 juill 2013Guidances/ucm070246.pdf 58 Disponible sur, p.2011, 2000. ,
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.265-278, 2004. ,
DOI : 10.1016/j.ejpb.2004.03.001
La physiologie du rein et des liquides corporels, Gaetan Morin ,
L'essentiel sur la néphrologie et l'urologie. 2ieme éd. Maloine ,
Edition 1971-1976, p.10646, 10646. ,
La transplantation rénale [Internet]. [cité 22 août 2013] Disponible sur: http://www.urofrance.org/fileadmin, 2010. ,
Rapport annuel, 2011. ,
Synthèse de l'activité régionale de prélèvement et de greffe en Rhône-Alpes, 2010. ,
Texte d'information sur la greffe rénale destiné aux adultes et aux enfants, 1999. ,
[Evaluation of glomerular filtration rate and proteinuria for the diagnosis of chronic kidney disease]. Néphrologie Thérapeutique, juill, vol.5, issue.4, pp.302-305, 2009. ,
Immunosuppression en transplantation r??nale, Progr??s en Urologie, vol.21, issue.4, pp.250-253, 2011. ,
DOI : 10.1016/j.purol.2010.08.048
La pharmacologie des immunosuppresseurs actuels. Médecine Thérapeutique. 3 mars 1999, pp.101-108 ,
Immunosuppressive treatments: mechanisms of action and clinical use]. Néphrologie Thérapeutique, déc, vol.7, issue.7, pp.566-581, 2011. ,
Disponible sur: http://www-ulpmed.ustrasbg.fr/medecine, 2013. ,
Immunosuppressive Drugs for Kidney Transplantation, New England Journal of Medicine, vol.351, issue.26, pp.2715-2729, 2004. ,
DOI : 10.1056/NEJMra033540
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients, J Am Soc Nephrol. 10 janv, vol.11, issue.1, pp.1-86, 2000. ,
Suivi th??rapeutique pharmacologique pour l???adaptation de posologie des m??dicaments, Le Pharmacien Hospitalier, vol.43, issue.173, 2004. ,
DOI : 10.1016/S0768-9179(08)70010-5
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference, Therapeutic Drug Monitoring, vol.31, issue.2, pp.139-152, 2009. ,
DOI : 10.1097/FTD.0b013e318198d092
Avis du 16 juillet Rapamune [Internet]. [cité 3 sept 2013, Disponible sur, 2008. ,
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation, Therapeutic Drug Monitoring, vol.28, issue.2 ,
DOI : 10.1097/01.ftd.0000199358.80013.bd
Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review, Transplantation, vol.85, issue.12, pp.1675-1685, 2008. ,
DOI : 10.1097/TP.0b013e3181744199
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation, Transplantation. 27 juill, vol.68, issue.2, pp.261-266, 1999. ,
Intérêt du suivi thérapeutique du mycophénolate mofétil, Lett Pharmacol, vol.16, issue.1, pp.5-11 ,
Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation, American Journal of Transplantation, vol.82, issue.1, pp.2496-2503, 2007. ,
DOI : 10.1097/00007691-200412000-00005
The need of mycophenolic acid monitoring in long-term renal transplants, Clinical Transplantation, vol.48, issue.1, pp.19-25, 2005. ,
DOI : 10.1093/ndt/14.suppl_4.33
Therapeutic Drug Monitoring of Mycophenolic Acid, Clinical Journal of the American Society of Nephrology, vol.2, issue.5, pp.1062-1072, 2007. ,
DOI : 10.2215/CJN.03861106
La substitution générique présente-t-elle un danger chez le patient greffé? ,
The Skinny on Narrow Therapeutic Index Drugs Used in Transplantation: A Brand vs. Generic Debate ,
SFT - Recommandation de la SFT sur l'utilisation des génériques des immunosuppresseurs. - Actualités: site de la SFT ,
Pharmacocinétique du mofétilmycophénolate en greffe hématopoïétique: étude d'un cas pédiatrique, p.2, 2008. ,
Traité de biopharmacie et pharmacocinétique. Vigot, 1985. ,
Single-dose, Two-way Crossover, Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects, Clinical Therapeutics, vol.33, issue.3, pp.378-390, 2011. ,
DOI : 10.1016/j.clinthera.2011.04.003
Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, two-way crossover study, Clinical Therapeutics, vol.32, issue.1, pp.171-178, 2010. ,
DOI : 10.1016/j.clinthera.2010.01.013
Bioavailability of a New Generic Formulation of Mycophenolate Mofetil MMF 500 Versus CellCept in Healthy Adult Volunteers, Transplantation Proceedings, vol.39, issue.4, pp.1233-1236, 2007. ,
DOI : 10.1016/j.transproceed.2007.03.055
The role of generics in transplantation: TM-MMF versus cellcept in healthy volunteers, Transplantation Proceedings, vol.36, issue.1, pp.84-85, 2004. ,
DOI : 10.1016/j.transproceed.2003.11.008
Mycophenolate mofetil 500-mg tablet under fasting conditions: Single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects, Clinical Therapeutics, vol.32, issue.3, pp.556-574, 2010. ,
DOI : 10.1016/j.clinthera.2010.03.008
The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results, Exp Clin Transplant Off J Middle East Soc Organ Transplant. déc, vol.8, issue.4, pp.292-296, 2010. ,
Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients ??? preliminary results of 6-month observation, Annals of Transplantation, vol.16, issue.4, pp.74-80, 2011. ,
DOI : 10.12659/AOT.882222
Immunosuppression With Generic Tacrolimus and Mycophenolate Mofetil in Renal Transplant Recipients: Preliminary Report in Chile, Transplantation Proceedings, vol.40, issue.3, pp.705-707, 2008. ,
DOI : 10.1016/j.transproceed.2008.02.056
Converting to a Generic Formulation of Mycophenolate Mofetil in Stable Kidney Transplant Recipients: 1 Year of Drug Surveillance and Outcome, Transplantation Proceedings, vol.39, issue.3, pp.602-605, 2007. ,
DOI : 10.1016/j.transproceed.2006.12.034
Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients, Transplant International, vol.23, issue.115, pp.680-686, 2012. ,
DOI : 10.1111/j.1432-2277.2012.01475.x
How Safe Is Conversion from Tacrolimus to Its Generic Drug????A Single Center Experience, Open Journal of Nephrology, vol.02, issue.04, pp.72-77, 2012. ,
DOI : 10.4236/ojneph.2012.24012
The Impact of Conversion From Prograf to Generic Tacrolimus in Liver and Kidney Transplant Recipients With Stable Graft Function, American Journal of Transplantation, vol.43, issue.9, pp.1861-1867, 2011. ,
DOI : 10.1111/j.1600-6143.2011.03615.x
Generic substitution of tacrolimus appears to be safe in the short term in clinically stable liver and kidney transplant patients, but monitoring of tacrolimus blood concentrations in individual patients is essentia, Disponible sur, 2013. ,
Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: Brief communication, Pediatric Transplantation, vol.40, issue.Suppl. 115 ,
DOI : 10.1111/j.1399-3046.2010.01393.x
A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients, American Journal of Transplantation, vol.14, issue.Suppl 2, pp.2825-2831, 2012. ,
DOI : 10.1111/j.1600-6143.2012.04174.x
The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function, Clinical Transplantation, vol.5, issue.2, pp.313-317, 2006. ,
DOI : 10.1016/S0149-2918(03)80161-3
Neoral-to-gengraf conversion in renal transplant recipients, Transplantation Proceedings, vol.35, issue.4, pp.1308-1313, 2003. ,
DOI : 10.1016/S0041-1345(03)00423-8
Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation, Transplantation, vol.74, issue.7, pp.1013-1017, 2002. ,
DOI : 10.1097/00007890-200210150-00020
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 15 déc, pp.1633-1635, 2005. ,
Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial, Kidney International, vol.77, issue.115, pp.12-16, 2010. ,
DOI : 10.1038/ki.2009.506
Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange, Journal of Transplantation, vol.33, issue.2, p.480642, 2011. ,
DOI : 10.1046/j.1600-6143.2003.00212.x
Switching Between Cyclosporin Formulations What are the Risks?, Drug Safety, vol.16, issue.6, pp.366-373, 1997. ,
DOI : 10.2165/00002018-199716060-00003
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A, Clinical Therapeutics, vol.25, issue.6, pp.1654-1669, 2001. ,
DOI : 10.1016/S0149-2918(03)80161-3
Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus, European Journal of Clinical Pharmacology, vol.22, issue.Suppl B, pp.361-366, 2006. ,
DOI : 10.1007/s00228-006-0109-z
Rapport 2012 sur l'application des lois de financement de la Sécurité sociale. Cour des comptes, septembre 2012, 1346358. ,
Communiqué de presse 3 juillet Recommandations de la LFCE concernant l'usage des médicaments antiépileptiques génériques chez les patients souffrant d'épilepsie, Communiqu%8E%20de%20Presse%20LFCE, 2007. ,
Position statement of the coverage of anticonvulsant drugs for the treatment of epilepsy, 2006. ,
Brand Spanking? The Presumptive Risks of Generic Antiepileptic Drugs, Epilepsy Currents, vol.11, issue.2, pp.54-55, 2011. ,
DOI : 10.5698/1535-7511-11.2.54
Clinical experience with generic levetiracetam in people with epilepsy, Epilepsia, vol.71, issue.4, pp.810-815, 2011. ,
DOI : 10.1111/j.1528-1167.2011.03025.x
Generic substitution in the treatment of epilepsy: Case evidence of breakthrough seizures, Neurology, vol.71, issue.7, pp.525-530, 2008. ,
DOI : 10.1212/01.wnl.0000319958.37502.8e
Generic Substitution of Levetiracetam Resulting in Increased Incidence of Breakthrough Seizures, Annals of Pharmacotherapy, vol.45, issue.5, p.27, 2011. ,
DOI : 10.1345/aph.1P765
Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy, Clinical Therapeutics, vol.29, issue.2, pp.334-341, 2007. ,
DOI : 10.1016/j.clinthera.2007.02.005
Clinical Outcomes Associated with Brand-to-Generic Phenytoin Interchange, Annals of Pharmacotherapy, vol.4, issue.5, pp.650-658, 2012. ,
DOI : 10.1345/aph.1Q601
Does generic lamotrigine lead to larger variations in plasma concentrations?]. Ugeskr Laeger, pp.2013-2015, 2007. ,
Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.43, issue.3, pp.314-322, 2012. ,
DOI : 10.1002/j.1875-9114.2012.01099.x
Generic Substitution of Antiepileptic Drugs: A Systematic Review of Prospective and Retrospective Studies, Annals of Pharmacotherapy, vol.39, issue.11, pp.1406-1415, 2011. ,
DOI : 10.1345/aph.1Q349
Generic Substitution of Lamotrigine Among Medicaid Patients with Diverse Indications, CNS Drugs, vol.21, issue.8, pp.707-716, 2012. ,
DOI : 10.2165/11634260-000000000-00000
Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs, Drugs, vol.14, issue.1, pp.605-621, 2010. ,
DOI : 10.2165/10898530-000000000-00000
Compte rendu de la réunion du mardi 27 mars 2012 ,
Hypothyroidism resulting from generic levothyroxine failure. J Am Board Fam Pr Am Board Fam Pr, juin, vol.4, issue.3, pp.167-170, 1991. ,
ANSM a demandé à Merck Serono une adaptation de la teneur en principe actif de Levothyrox ,
Pénurie de Levothyrox, Communiqué du 17 aout 2013 ,
Generic Levothyroxine Compared With Synthroid in Young Children With Congenital Hypothyroidism, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.2, pp.653-658, 2013. ,
DOI : 10.1210/jc.2012-3558
-Thyroxine Are Not Bioequivalent for Children With Severe Congenital Hypothyroidism, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.2, pp.610-617, 2013. ,
DOI : 10.1210/jc.2012-3125
Bioequivalence studies for levothyroxine, The AAPS Journal, vol.7, issue.1, pp.47-53, 2005. ,
DOI : 10.1208/aapsj070106
Bioequivalence of thyroid preparations: The final word?, The AAPS Journal, vol.7, issue.1, pp.59-60, 2005. ,
DOI : 10.1208/aapsj070108
Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable?, Thyroid, vol.14, issue.3, pp.191-200, 2004. ,
DOI : 10.1089/105072504773297867
Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator, Antimicrobial Agents and Chemotherapy, vol.54, issue.8 ,
DOI : 10.1128/AAC.01044-09
Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits, Antimicrobial Agents and Chemotherapy, vol.57, issue.3, pp.1157-1162, 2013. ,
DOI : 10.1128/AAC.01669-12
Quality Assessment of U.S. Marketplace Vancomycin for Injection Products Using High-Resolution Liquid Chromatography-Mass Spectrometry and Potency Assays, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.2824-2830, 2012. ,
DOI : 10.1128/AAC.00164-12
Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia, Journal of Infection, vol.59, issue.4, pp.277-280, 2009. ,
DOI : 10.1016/j.jinf.2009.08.005
Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus, Journal of Infection and Chemotherapy, vol.17, issue.1, pp.30-33, 2011. ,
DOI : 10.1007/s10156-010-0094-0
Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics, BMC Clinical Pharmacology, vol.38, issue.1, 2009. ,
DOI : 10.7164/antibiotics.38.51
Compliance in Health Care, 1979. ,
Penser autrement l???observance m??dicamenteuse??: d???une posture injonctive ?? une alliance th??rapeutique entre le patient et le soignant ??? Concepts et d??terminants, Annales Pharmaceutiques Fran??aises, vol.70, issue.1, pp.15-25, 2012. ,
DOI : 10.1016/j.pharma.2011.10.003
Compliance, observance ou adh??sion th??rapeutique : de quoi parlons-nous ?, Revue des Maladies Respiratoires, vol.22, issue.1, pp.31-34, 2005. ,
DOI : 10.1016/S0761-8425(05)85433-6
Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, pp.487-497, 2005. ,
DOI : 10.1056/NEJMra050100
Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation, Transplantation, vol.83, issue.7, pp.858-873, 2007. ,
DOI : 10.1097/01.tp.0000258599.65257.a6
Adherence in liver transplant recipients. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc, juill, vol.17, issue.7, pp.760-770, 2011. ,
Adherence to the Medical Regimen During the First Two Years After Lung Transplantation, Transplantation, vol.85, issue.2, pp.193-202, 2008. ,
DOI : 10.1097/TP.0b013e318160135f
Adherence to the Therapeutic Regimen in Heart, Lung, and Heart-Lung Transplant Recipients, The Journal of Cardiovascular Nursing, vol.20, issue.Supplement, pp.88-98, 2005. ,
DOI : 10.1097/00005082-200509001-00010
Medication adherence among heart and/or lung transplant recipients: An exploratory study, Patient Prefer Adherence, vol.2, pp.115-120, 2008. ,
Non-adherence with drug treatment after heart or lung transplantation in adults: A systematic review, Patient Education and Counseling, vol.81, issue.2, pp.148-154, 2010. ,
DOI : 10.1016/j.pec.2010.04.013
Nonadherent Behaviors After Solid Organ Transplantation, Transplantation Proceedings, vol.43, issue.1, pp.318-323, 2011. ,
DOI : 10.1016/j.transproceed.2010.09.103
Factors related to immunosuppressant medication adherence in renal transplant recipients, Clinical Transplantation, vol.31, issue.5, pp.706-713, 2012. ,
DOI : 10.1111/j.1399-0012.2011.01589.x
Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients, Transplantation Journal, vol.95, issue.2, pp.333-340, 2013. ,
DOI : 10.1097/TP.0b013e3182725532
Preferential Adherence to Immunosuppressive Over Nonimmunosuppressive Medications in Kidney Transplant Recipients, Transplantation Proceedings, vol.42, issue.9, pp.3578-3585, 2010. ,
DOI : 10.1016/j.transproceed.2010.08.027
Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients, Research in Social and Administrative Pharmacy, vol.8, issue.3, pp.228-239, 2012. ,
DOI : 10.1016/j.sapharm.2011.04.001
Satisfaction and adherence with immunosuppressant treatment in renal transplant patients living with a working graft, Journal of Nephrology, vol.26, issue.2, pp.297-305, 2013. ,
DOI : 10.5301/jn.5000132
Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus, Nefrol Publicación Of Soc Española Nefrol, vol.31, issue.6, pp.690-696, 2011. ,
Education and counseling of renal transplant recipients, Journal of Nephrology, vol.25, issue.6, pp.879-889, 2012. ,
DOI : 10.5301/jn.5000227
The spectrum of nonadherence with medication in heart, liver, and lung tranplant patients assessed in various ways, Transplant International, vol.17, issue.9, pp.882-91, 2011. ,
DOI : 10.1111/j.1432-2277.2011.01296.x
Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation, Transplantation, vol.83, issue.7, pp.858-873, 2007. ,
DOI : 10.1097/01.tp.0000258599.65257.a6
Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review, Transplant International, vol.5, issue.10, pp.1121-1133, 2005. ,
DOI : 10.1097/00007890-200010270-00020
Adherence to long-term therapies: Evidence for action [Internet]. [cité 21 sept 2013, Disponible sur, 2003. ,
Prédire l'adhésion aux traitements immunosuppresseurs chez le patient transplanté : étude PrATIS. 26 sept 2011 [cité 21 sept 2013]; Disponible sur ,
Generic Immunosuppression: Deciphering the Message Our Patients are Receiving, Annals of Pharmacotherapy, vol.56, issue.5, pp.671-677, 2012. ,
DOI : 10.1345/aph.1R028
A survey to determine the views of renal transplant patients on generic substitution in the UK, Transplant International, vol.332, issue.8, pp.770-779, 2011. ,
DOI : 10.1111/j.1432-2277.2011.01268.x
Renal patients' views on generic prescribing and substitution: example from the United Arab Emirates. East Mediterr Heal J Rev Santé Méditerranée Orient Al-Majallah Al- S.h.H?yah Li-Sharq Al-Mutawassit, avr, vol.19, issue.4, pp.373-381, 2013. ,
Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy, Journal of Transplantation, vol.1, issue.1, 2013. ,
DOI : 10.2215/CJN.01630210
Generic Immunosuppression in Solid Organ Transplantation, Transplantation, vol.93, issue.7, pp.657-665, 2012. ,
DOI : 10.1097/TP.0b013e3182445e9d
What are patients' attitudes towards generic drugs? The example of metformin]. Rev Médicale Suisse, pp.1005-1009, 2013. ,
The Implications of Choice, Archives of Internal Medicine, vol.166, issue.3, pp.332-337, 2006. ,
DOI : 10.1001/archinte.166.3.332
Associations between generic substitution and patients' attitudes, beliefs and experiences, European Journal of Clinical Pharmacology, vol.28, issue.5, 2013. ,
DOI : 10.1007/s00228-013-1539-z
Interchangeability of generics [Internet]. [cité 29 août 2013] Disponible sur ,
Generic substitution: additional challenge for adherence in hypertensive patients?, Current Medical Research and Opinion, vol.25, issue.10, pp.2515-2521, 2009. ,
DOI : 10.1185/03007990903192223
Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway, European Journal of Clinical Pharmacology, vol.65, issue.2, pp.193-201, 2011. ,
DOI : 10.1007/s00228-010-0960-9
What do primary care patients think about generic drugs?, Int. Journal of Clinical Pharmacology and Therapeutics, vol.43, issue.10, pp.472-479, 2005. ,
DOI : 10.5414/CPP43472
Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany ,
Variations in Pill Appearance of Antiepileptic Drugs and the Risk of Nonadherence, JAMA Internal Medicine, vol.173, issue.3, pp.202-208, 2013. ,
DOI : 10.1001/2013.jamainternmed.997
Assessing lay beliefs about generic medicines: Development of the generic medicines scale, Psychology, Health & Medicine, vol.10, issue.3, pp.311-321, 2009. ,
DOI : 10.1016/S0212-6567(05)70550-3
Generic substitution in the treatment of epilepsy: Patient attitudes and perceptions, Epilepsy & Behavior, vol.26, issue.1, pp.64-66, 2013. ,
DOI : 10.1016/j.yebeh.2012.10.032
The nocebo effect: a reason for patients' non-adherence to generic substitution? Pharm, juill, vol.65, issue.7, pp.451-456, 2010. ,
Les génériques sont-ils un facteur d'économies pour l'Assurance Maladie? Fiche 65 ,
Le médicament générique: des attentes à la réalité, Réalités Ind. (FEV, pp.66-68 ,
Les génériques en immunosuppression, Disponible sur, pp.3-9, 2012. ,
Generic Immunosuppressants in Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.17, issue.3, pp.285-290, 2011. ,
DOI : 10.1016/j.bbmt.2010.11.006
Healthcare costs in renal transplant recipients using branded versus generic ciclosporin, Applied Health Economics and Health Policy, vol.38, issue.7, pp.61-68, 2010. ,
DOI : 10.1007/BF03256166
Carbamazepine toxicity resulting from generic substitution, Neurology, vol.43, issue.12, pp.2696-2697, 1993. ,
DOI : 10.1212/WNL.43.12.2696
The Economic Consequences of Generic Substitution for Antiepileptic Drugs in a Public Payer Setting: The Case of Lamotrigine, Disease Management, vol.10, issue.4, pp.216-225, 2007. ,
DOI : 10.1089/dis.2007.104649
The risks and costs of multiple-generic substitution of topiramate, Neurology, vol.72, issue.24, pp.2122-2129, 2009. ,
DOI : 10.1212/WNL.0b013e3181aa5300
Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries, Current Medical Research and Opinion, vol.25, issue.7, pp.1793-1805, 2009. ,
DOI : 10.1185/03007990903044374
Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting, Current Medical Research and Opinion, vol.24, issue.4, pp.1069-1081, 2008. ,
DOI : 10.1185/030079908X280572
Economic burden associated with the use of generic antiepileptic drugs in the United States, Epilepsy & Behavior, vol.18, issue.4, pp.437-444, 2010. ,
DOI : 10.1016/j.yebeh.2010.05.015
Rapport de l'Académie nationale de Pharmacie sur les médicaments génériques du 24 Octobre 2012 ,
Utilisation de médicaments génériques pour l'immunosuppression après greffe d'organes [Internet]. [cité 10 sept 2013, Disponible sur ,
Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants, American Journal of Transplantation, vol.37, issue.3, pp.1211-1215, 2003. ,
DOI : 10.1001/jama.283.18.2445
Drug substitution in transplantation: A National Kidney Foundation white paper, American Journal of Kidney Diseases, vol.33, issue.2, pp.389-397, 1999. ,
DOI : 10.1016/S0272-6386(99)70318-5
Generic Drug Immunosuppression in Thoracic Transplantation: An ISHLT Educational Advisory, The Journal of Heart and Lung Transplantation, vol.28, issue.7, pp.655-660, 2009. ,
DOI : 10.1016/j.healun.2009.05.001
Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy, Clinical Transplantation, vol.19, issue.5, pp.439-448, 2000. ,
DOI : 10.1016/S0041-1345(98)00408-4
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations, Transplant Proc. févr, vol.27, issue.1, pp.837-839, 1995. ,
Generic Immunosuppressants in Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.17, issue.3, pp.285-290, 2011. ,
DOI : 10.1016/j.bbmt.2010.11.006